Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dare Bioscience Inc. (DARE)

1.27   -0.11 (-7.97%) 01-24 16:00
Open: 1.36 Pre. Close: 1.38
High: 1.38 Low: 1.25
Volume: 1,211,440 Market Cap: 25M
Dare Bioscience Inc is a healthcare company. The company develops and commercializes products in women's reproductive health. Its segment includes spectrum of categories like: contraception, vaginal health, pain and fertility.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.382 - 1.39 1.39 - 1.396
Low: 1.231 - 1.241 1.241 - 1.248
Close: 1.257 - 1.272 1.272 - 1.282

Technical analysis

as of: 2020-01-24 4:30:56 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.96     One year: 2.59
Support: Support1: 0.80    Support2: 0.67
Resistance: Resistance1: 1.68    Resistance2: 2.22
Pivot: 1.26
Moving Average: MA(5): 1.53     MA(20): 1.15
MA(100): 0.88     MA(250): 0.92
MACD: MACD(12,26): 0.18     Signal(9): 0.16
Stochastic oscillator: %K(14,3): 45.77     %D(3): 54.07
RSI: RSI(14): 54.02
52-week: High: 3.25  Low: 0.69  Change(%): 57.0
Average Vol(K): 3-Month: 166500  10-Days: 853097

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
DARE has closed below upper band by 49.2%. Bollinger Bands are 562.5% wider than normal. The large width of the bands suggest high volatility as compared to DARE's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 17 Jan 2020 17:19:20 +0000
Analysts: 3 Healthcare Stocks That Could Gain 35% — Or More

Mon, 13 Jan 2020 14:59:39 +0000
Bayer, Daré Bioscience Sign License Agreement On Ovaprene

Tue, 09 Apr 2019 02:47:55 +0000
CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub

Tue, 16 Apr 2019 14:32:09 +0000
Tuesday 4/16 Insider Buying Report: DARE, TLRD

Wed, 13 Jun 2018 14:45:21 +0000
Wednesday 6/13 Insider Buying Report: DARE, BFST

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19.68
Shares Float (M) 14.35
% Held by Insiders 18.95
% Held by Institutions 4.83
Shares Short (K) 756
Shares Short P. Month (K)

Stock Financials

EPS -1.013
Book Value (p.s.) 0.110
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -114.5
Return on Equity (ttm) -233.7
Qtrly Rev. Growth
Gross Profit (p.s.) -0.032
Sales Per Share
EBITDA (p.s.) -0.683
Qtrly Earnings Growth
Operating Cash Flow (M) -12.22
Levered Free Cash Flow (M) -7.56

Stock Valuations

P/E -1.25
P/E Growth Ratio -0.08
P/BV 11.55
P/S
P/CF -2.05

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-07-19
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.